Format

Send to

Choose Destination
See comment in PubMed Commons below
Neurology. 2006 Jan 24;66(2 Suppl 1):S79-85.

Apolipoprotein E and Alzheimer disease.

Author information

  • 1Gladstone Institute of Neurological Disease, Department of Pathology, University of California, San Francisco, CA, USA. yhuang@gladstone.ucsf.edu

Abstract

Apolipoprotein (apo) E, a multifunctional protein with central roles in lipid metabolism and neurobiology, has three common isoforms (apoE2, apoE3, and apoE4) with different effects on lipid homeostasis and neurobiology. Unlike apoE3, the most common isoform, apoE4, is associated with increased risk of developing Alzheimer disease (AD) and other neurodegenerative disorders. Although the mechanisms underlying apoE4's action in AD pathogenesis are still poorly understood, emerging data strongly suggest that apoE4 contributes to this disease by interacting with different factors through various pathways. Thus, multiple molecular and cellular mechanisms should be considered when anti-AD drugs are developed based on apoE studies.

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire
    Loading ...
    Write to the Help Desk